Editor's Note: This Manuscript was accepted for publication January 24, 2008.
Outcomes of Patients with N3 Neck Nodes Treated with Chemoradiation†
Article first published online: 2 JAN 2009
Copyright © 2008 The Triological Society
Volume 118, Issue 6, pages 995–998, June 2008
How to Cite
Ballonoff, A., Raben, D., Rusthoven, K. E., Bassetti, M., Kane, M., Song, J. I. and Chen, C. (2008), Outcomes of Patients with N3 Neck Nodes Treated with Chemoradiation. The Laryngoscope, 118: 995–998. doi: 10.1097/MLG.0b013e31816a7120
- Issue published online: 2 JAN 2009
- Article first published online: 2 JAN 2009
- Head and neck cancer;
- distant metastases
Objective: To evaluate the outcomes of patients with locally advanced head and neck squamous cell carcinoma with N3 neck nodes treated with definitive chemoradiation.
Study Design: Retrospective review.
Methods: Thirty-two patients with nonmetastatic locally advanced head and neck squamous cell carcinoma and N3 neck disease treated with concurrent chemoradiation therapy were evaluated. Overall survival, disease- free survival, locoregional control, and distant control were recorded.
Results: Median follow-up for surviving patients was 25 (range, 3–93) months. Seventeen of 32 (53%) patients failed, 13 in distant sites only, 2 in the neck only, 1 in the neck and a distant site, and 1 in the neck and primary site. The absolute rates of locoregional control and distant control were 88% and 56%, respectively. Actuarial overall survival and disease-free survival at 2 years were 51% and 29%, respectively.
Conclusion: Patients with N3 neck disease treated with chemoradiation experience a very high rate of distant failure. Future studies investigating the role of additional systemic therapy in these patients are warranted.